This week in the Clinical Research Update are three studies that focus on different groups of patients. The first is an update from the Tsepamo study about the prevalence of neural tube defects when mothers are taking dolutegravir. The second is about the PrEP continuum of care and new HIV infections. Finally, there is a study about the safety and efficacy of long-acting injectable cabotegravir.
You can view the full update at
https://aahivm.org/clinical-research-update-080420/.------------------------------
Jeffrey Kirchner
Lancaster General Health Physicians (LGHP) - Comprehensive Care
Lancaster PA
------------------------------